Related Experiment Videos
Postprandial lipoprotein metabolism and atherosclerosis
1King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Stockholm, Sweden.
Current Opinion in Lipidology
|June 1, 1995
Summary
Dietary fat transport via chylomicron remnants may not directly cause atherosclerosis but could worsen the atherogenicity of other lipoproteins. This review examines the current literature on chylomicron remnant metabolism and its role in cardiovascular disease.
Area of Science:
- Lipid metabolism
- Cardiovascular disease
- Atherosclerosis
Background:
- Chylomicrons distribute dietary energy to tissues.
- Chylomicron remnants are proposed to be atherogenic.
- Delayed remnant clearance correlates with abnormal lipoproteins.
Purpose of the Study:
- To critically review the literature on chylomicron remnant metabolism.
- To evaluate the role of chylomicron remnants in atherogenesis.
- To determine if chylomicron remnants directly cause or enhance atherosclerosis.
Main Methods:
- Literature review of current scientific publications.
- Analysis of studies on lipoprotein metabolism and clearance.
- Examination of the association between remnant levels and cardiovascular risk factors.
Main Results:
- Plasma concentrations of chylomicron remnants are very low.
- Evidence suggests remnants may enhance atherogenicity of other lipoproteins rather than being directly atherogenic.
- Delayed clearance is linked to altered lipoprotein composition.
Conclusions:
- Chylomicron remnant metabolism may indirectly contribute to atherosclerosis.
- Further research is needed to fully elucidate the role of chylomicron remnants in cardiovascular health.
- Understanding remnant clearance is crucial for assessing cardiovascular risk.